Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

100 trials found

Recruiting 999,999 target

Integrated Cancer Repository for Cancer Research

University of Nebraska

NCT02012699

Recruiting 150,000 target

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Children's Hospital of Philadelphia

NCT02493478

Recruiting 120,000 target

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Manuel Monreal

NCT02832245

Recruiting 100,000 target

US National OCS Heart Perfusion (OHP) Registry

TransMedics

NCT05915299

Recruiting 80,000 target

Generic Database of Very Low Birth Weight Infants

NICHD Neonatal Research Network

NCT00063063

Recruiting 75,000 target

TrialNet Pathway to Prevention of T1D

University of South Florida

NCT00097292

Recruiting 68,000 target

Follow-up Visit of High Risk Infants

NICHD Neonatal Research Network

NCT00009633

Recruiting NA 61,770 target

TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

Yale University

NCT05723614

Recruiting 50,000 target

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio

NCT03452774

Recruiting 40,000 target

Stroke Thrombectomy and Aneurysm Registry

Medical University of South Carolina

NCT04994756

Recruiting 40,000 target

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

Yale University

NCT04237701

Recruiting 35,000 target

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

CHDI Foundation

NCT01574053

Recruiting 30,000 target

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Agendia

NCT03053193

Recruiting 25,000 target

Parkinson's Foundation PD GENEration Genetic Registry

Parkinson's Foundation

NCT04994015

Recruiting Phase 4 20,000 target

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Duke University

NCT04262206

Recruiting 20,000 target

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Duke University

NCT02418442

Recruiting 20,000 target

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Freenome Holdings

NCT06122077

Recruiting 20,000 target

Pancreatic Cancer Early Detection Consortium

Arbor Research Collaborative for Health

NCT04970056

Recruiting 15,000 target

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Target PharmaSolutions

NCT02815891

Recruiting 15,000 target

Patient Retrospective Outcomes (PRO)

Boston Scientific Corporation

NCT01550575

Recruiting NA 13,000 target

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Washington University School of Medicine

NCT05991453

Recruiting Phase 3 13,000 target

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Hoffmann-La Roche

NCT07177352

Recruiting 12,000 target

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Genzyme, a Sanofi Company

NCT00358943

Recruiting Phase 3 10,450 target

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Eli Lilly and Company

NCT07157774

Recruiting 10,000 target

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Cure HHT

NCT06259292

Recruiting Phase 2 10,000 target

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Eli Lilly and Company

NCT05986292

Recruiting 10,000 target

An Evaluation of Hip Preservation Outcomes

Yale University

NCT05746533

Recruiting Phase 3 9,000 target

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins University

NCT02000089

Recruiting 9,000 target

Fabry Disease Registry & Pregnancy Sub-registry

Genzyme, a Sanofi Company

NCT00196742

Recruiting Phase 4 7,410 target

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA Office of Research and Development

NCT02915198

Recruiting 7,000 target

Genetic Analysis of Keloids

UConn Health

NCT01619553

Recruiting Phase 3 6,150 target

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Population Health Research Institute

NCT04774159

Recruiting NA 6,080 target

Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2

Massachusetts General Hospital

NCT07166861

Recruiting NA 6,030 target

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Yale University

NCT05884190

Recruiting Phase 3 6,000 target

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Boehringer Ingelheim

NCT06424288

Recruiting Phase 4 6,000 target

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Duke University

NCT06909565

Recruiting Phase 3 5,500 target

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

AstraZeneca

NCT05952557

Recruiting NA 5,200 target

MyChart Proxy Outreach to Parents (MyPOP)

Yale University

NCT05989308

Recruiting 5,000 target

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

National Cancer Institute LAO

NCT02474160

Recruiting Phase 2 5,000 target

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

QuantumLeap Healthcare Collaborative

NCT01042379

Recruiting 5,000 target

Rheumatology Patient Registry and Biorepository

Yale University

NCT04402086

Recruiting 5,000 target

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

Prostate Cancer Clinical Trials Consortium

NCT03151629

Recruiting 5,000 target

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Michael Shy

NCT01193075

Recruiting 5,000 target

The Rett Syndrome Global Registry

Rett Syndrome Research Trust

NCT04900493

Recruiting Phase 3 5,000 target

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

AstraZeneca

NCT06742723

Recruiting 5,000 target

Prospective SPINE Registry

Xtant Medical

NCT04176562

Recruiting 5,000 target

The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry

Yale University

NCT06030063

Recruiting 5,000 target

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Boston Scientific Corporation

NCT04674969

Recruiting NA 4,700 target

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA Office of Research and Development

NCT05486572

Recruiting 4,700 target

Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

Sir Mortimer B. Davis - Jewish General Hospital

NCT06888388

Recruiting 4,500 target

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Michael J. Fox Foundation for Parkinson's Research

NCT04477785

Recruiting Phase 3 4,300 target

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

AstraZeneca

NCT05774951

Recruiting Phase 3 4,200 target

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Boehringer Ingelheim

NCT06935370

Recruiting 4,000 target

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

Fairtility

NCT07017972

Recruiting 4,000 target

Fecal Microbiota Transplant National Registry

American Gastroenterological Association

NCT03325855

Recruiting 3,750 target

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis

Yale University

NCT06172660

Recruiting Phase 3 3,500 target

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Merck Sharp & Dohme

NCT03486873

Recruiting 3,375 target

Shield Post-Approval Study Protocol

Guardant Health

NCT06880055

Recruiting Phase 3 3,200 target

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Icahn School of Medicine at Mount Sinai

NCT04045665

Recruiting 3,000 target

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Duke University

NCT01915511

Recruiting 3,000 target

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

American Thrombosis and Hemostasis Network

NCT04398628

Recruiting NA 3,000 target

Optimizing Tracheal Intubation Outcomes and Neonatal Safety

Children's Hospital of Philadelphia

NCT05838690

Recruiting 3,000 target

Pulmonary Hypertension Association Registry

Pulmonary Hypertension Association

NCT04071327

Recruiting NA 2,998 target

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Melanoma and Skin Cancer Trials Limited

NCT03860883

Recruiting NA 2,700 target

I-DECIDE After Bronchiolitis Hospitalization

Seattle Children's Hospital

NCT07243652

Recruiting 2,500 target

Total Shoulder Arthroplasty Multi-Center Registry

Arthrex

NCT03511586

Recruiting 2,400 target

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Veracyte

NCT06426628

Recruiting NA 2,400 target

MiSight 1 Day Safety Post-Approval Study

CooperVision

NCT05285527

Recruiting NA 2,300 target

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Weill Medical College of Cornell University

NCT04124120

Recruiting NA 2,298 target

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

University of Colorado, Denver

NCT05530343

Recruiting NA 2,250 target

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Edwards Lifesciences

NCT04889872

Recruiting NA 2,200 target

Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure

University of Colorado, Denver

NCT06526988

Recruiting NA 2,145 target

A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial

University of Pittsburgh

NCT05805709

Recruiting NA 2,136 target

Left vs Left Randomized Clinical Trial

Baylor College of Medicine

NCT05650658

Recruiting Phase 3 2,130 target

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

AstraZeneca

NCT07431281

Recruiting Phase 4 2,076 target

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Guerbet

NCT04373564

Recruiting 2,000 target

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

PSC Partners Seeking a Cure

NCT06297993

Recruiting 2,000 target

ASSESS ALL ALS Study

St. Joseph's Hospital and Medical Center, Phoenix

NCT06578195

Recruiting 2,000 target

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Oxford Biodynamics

NCT06635954

Recruiting 2,000 target

Pompe Disease Registry Protocol

Genzyme, a Sanofi Company

NCT00231400

Recruiting Phase 3 1,980 target

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Eli Lilly and Company

NCT07321886

Recruiting NA 1,912 target

Adaptive Decision Support for Addiction Treatment Master

Yale University

NCT06799117

Recruiting 1,850 target

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

AstraZeneca

NCT06465810

Recruiting Phase 3 1,800 target

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Cytokinetics

NCT06736574

Recruiting NA 1,800 target

M2VA Pain Care Pathway

Yale University

NCT06526143

Recruiting Phase 3 1,800 target

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera

NCT07284875

Recruiting Phase 3 1,755 target

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Boehringer Ingelheim

NCT06872892

Recruiting 1,715 target

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Memorial Sloan Kettering Cancer Center

NCT04291612

Recruiting Phase 3 1,700 target

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Boehringer Ingelheim

NCT06238622

Recruiting Phase 3 1,700 target

Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera

NCT07284901

Recruiting Phase 3 1,656 target

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Children's Oncology Group

NCT06401330

Recruiting NA 1,600 target

The CONFORM Pivotal Trial

Conformal Medical

NCT05147792

Recruiting Phase 3 1,600 target

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Sanofi

NCT06141473

Recruiting 1,600 target

National Cancer Institute "Cancer Moonshot Biobank"

National Cancer Institute (NCI)

NCT04314401

Recruiting NA 1,600 target

StrokeNet Thrombectomy Endovascular Platform

Medical University of South Carolina

NCT06289985

Recruiting Phase 3 1,600 target

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Summit Therapeutics

NCT05899608

Recruiting 1,600 target

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Bristol-Myers Squibb

NCT05489705

Recruiting Phase 3 1,594 target

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

European Myeloma Network B.V.

NCT05243797

Recruiting Phase 3 1,590 target

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Janssen Research & Development

NCT05552222

Recruiting Phase 2 1,541 target

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Celgene

NCT03435796

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →